Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Part of paid clinical trials in Little Rock, Arkansas.
- Sponsor
- Axsome Therapeutics, Inc.
- Study ID
- NCT07398417
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Fibromyalgia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- AXS-14 (Esreboxetine) — DRUGAXS-14 tablets taken once daily
- Placebo — DRUGPlacebo tablets taken once daily
Study Details
The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia.
Key Dates
- Start date
- Jan 14, 2026
- Status verified
- Feb 2026
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 620 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: AXS-14 (esreboxetine)* Up to 12 weeks in the open-label period; * Up to 12 weeks in the randomized double-blind period (if applicable)
- Placebo Comparator: Placebo• Up to 12 weeks in the randomized double-blind period (if applicable)
Primary Outcome Measure
Time from randomization to loss of therapeutic response [ Time Frame: 12 Weeks ]
Central Contacts
- Study Director212-332-5061
Locations (16)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Clinical Research Site | Little Rock | Arkansas | 72211 | - |
| Clinical Research Site | Santa Ana | California | 92705 | - |
| Clinical Research Site | Cromwell | Connecticut | 06416 | - |
| Clinical Research Site | Jacksonville | Florida | 32256 | - |
| Clinical Research Site | Orlando | Florida | 32801 | - |
| Clinical Research Site | Tampa | Florida | 33634 | - |
| Clinical Research Site | Atlanta | Georgia | 30329 | - |
| Clinical Research Site | Overland Park | Kansas | 66209 | - |
| Clinical Research Site | Louisville | Kentucky | 40205 | - |
| Clinical Research Site | Prairieville | Louisiana | 70769 | - |
| Clinical Research Site | Springfield | Missouri | 65807 | - |
| Clinical Research Site | Town and Country | Missouri | 63017 | - |
| Clinical Research Site | Tulsa | Oklahoma | 74133 | - |
| Clinical Research Site | Charleston | South Carolina | 29407 | - |
| Clinical Research Site | Memphis | Tennessee | 38119 | - |
| Clinical Research Site | Prosper | Texas | 75078 | - |
Find similar trials in Little Rock, AR
Related Studies
- Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain SyndromesRecruiting · University of Florida · Gainesville, Florida
- Effects of Breathing and Attention Training (BAT) on Pain ModulationRecruiting · University of Florida · Gainesville, Florida
- Rheumatology Diet StudyRecruiting · University of Central Florida · Orlando, Florida
- Auricular Neuromodulation in Veterans With FibromyalgiaRecruiting · VA Office of Research and Development · Decatur, Georgia